[HTML][HTML] Functionalized niosomes as a smart delivery device in cancer and fungal infection

P Aparajay, A Dev - European journal of pharmaceutical sciences, 2022 - Elsevier
Various diseases remain untreated due to lack of suitable therapeutic moiety or a suitable
drug delivery device, especially where toxicities and side effects are the primary reason for …

[HTML][HTML] Using inorganic nanoparticles to fight fungal infections in the antimicrobial resistant era

T Huang, X Li, M Maier, NM O'Brien-Simpson… - Acta Biomaterialia, 2023 - Elsevier
Fungal infections pose a serious threat to human health and livelihoods. The number and
variety of clinically approved antifungal drugs is very limited, and the emergence and rapid …

The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules

P Brandao, C Marques, AJ Burke, M Pineiro - European journal of …, 2021 - Elsevier
Oxindole derivatives are known for their great interest in the field of Medicinal Chemistry, as
they display vast biological activities. Recent efforts concerning the preparation of oxindole …

Sources of antifungal drugs

G Vanreppelen, J Wuyts, P Van Dijck, P Vandecruys - Journal of Fungi, 2023 - mdpi.com
Due to their eukaryotic heritage, the differences between a fungal pathogen's molecular
makeup and its human host are small. Therefore, the discovery and subsequent …

Camphor and eucalyptol—Anticandidal spectrum, antivirulence effect, efflux pumps interference and cytotoxicity

M Ivanov, A Kannan, DS Stojković, J Glamočlija… - International Journal of …, 2021 - mdpi.com
Candida albicans represents one of the most common fungal pathogens. Due to its
increasing incidence and the poor efficacy of available antifungals, finding novel antifungal …

Therapies and vaccines based on nanoparticles for the treatment of systemic fungal infections

B Kischkel, SA Rossi, SR Santos… - Frontiers in cellular …, 2020 - frontiersin.org
Treatment modalities for systemic mycoses are still limited. Currently, the main antifungal
therapeutics include polyenes, azoles, and echinocandins. However, even in the setting of …

Biocontrol of volatile organic compounds obtained from Bacillus subtilis CL2 against Aspergillus flavus in peanuts during storage

L Ling, K Jiang, W Cheng, Y Wang, M Pang, H Luo… - Biological Control, 2022 - Elsevier
One of the saprophytic fungi that contaminates crops with carcinogenic aflatoxins is
Aspergillus flavus. During pre-harvest and post-harvest, microbial produced bioactive …

Fun (gi) omics: Advanced and diverse technologies to explore emerging fungal pathogens and define mechanisms of antifungal resistance

B Ball, M Langille, J Geddes-McAlister - MBio, 2020 - Am Soc Microbiol
The landscape of infectious fungal agents includes previously unidentified or rare
pathogens with the potential to cause unprecedented casualties in biodiversity, food …

Rational design of an antifungal polyacrylamide library with reduced host-cell toxicity

S Schaefer, TTP Pham, S Brunke, B Hube… - … Applied Materials & …, 2021 - ACS Publications
Life-threatening invasive fungal infections represent an urgent threat to human health
worldwide. The limited set of antifungal drugs has critical constraints such as resistance …

The future of antifungal drug therapy: novel compounds and targets

C Mota Fernandes, D Dasilva… - Antimicrobial agents …, 2021 - Am Soc Microbiol
Fungal infections are a universal problem and are routinely associated with high morbidity
and mortality rates in immunocompromised patients. Existing therapies comprise five …